On Yahoo, the average price target is at $5.20. I would not be surprised if by this time next year it exceeded that price target when Mister Market takes notice. This could be a great growth stock.
The finances look good (not great, but good), the FDA approvals are behind us, Teva is playing ball, Xyosted's launch is ready to roll, everything is set for a great 2019.
We could even have a BO, even though that's not what I would prefer.